Nkarta, Inc. (NKTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.49 |
| Open | 7.63 |
| Bid | 7.47 x 100 |
| Ask | 7.63 x 100 |
| Day's range | 7.25 - 7.77 |
| 52-week range | 1.28 - 16.24 |
| Volume | |
| Avg. volume | 996,069 |
| Market cap | 530.621M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
Why Nkarta Stock Just Boomeranged Following A Massive Dive On Friday
Nkarta stock surged Monday — partially reversing a 31% dive on Friday — after unveiling promising test results for its lymphoma treatment.
- GuruFocus.com
Nkarta Inc (NKTX) Posts Full Year 2023 Financial Results: A Focus on NKX019 and Pipeline Realignment
Aligns with EPS Projections, Prioritizes NKX019 in Autoimmune Diseases Over NKX101
- Investor's Business Daily
Why Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line
Top-notch Nkarta stock tumbled Friday after the biotech company deprioritized a cancer drug in favor of an experimental lupus treatment.
© 2024 Yahoo. All rights reserved.